Longjin pharmaceutical co.002750
80.660
Application No | Application date | Publication (Announcement) No. | Invention title |
CN201910188258.1 | 1995.04.10 | CN109700853A | A type of composite and its application in preparation of drugs for epilepsy treatment |
CN201810938621.2 | 2006.05.19 | CN109020938A | A method to prepare myricetin |
CN201810938625.0 | 2006.05.19 | CN109053837A | A method to prepare 7-O- glycosylated myricetin |
CN201810794310.3 | 2006.05.26 | CN108670972A | The pharmaceutical composition for preventing/ curing ischemic cardiovascular and cerebrovascular diseases and its application |
CN201810115569.0 | 2006.05.26 | CN108079285A | Aspartate stabilizer for venom enzyme preparations and its preparation methods |
CN201810115670.6 | 2007.08.31 | CN108245669A | A type of stable defibrase injection and its preparation method |
CN201810115677.8 | 2008.09.26 | CN108273067A | Glutamic acid stabilizer for venom enzyme and its preparation method |
CN201711420823.X | 2009.11.09 | CN107854630A | Rice bran extract and its preparation method and application |
CN201710372392.8 | 2009.11.09 | CN106967139A | A type of erigeron breviscapus ponicidin crystal form and its preparation method |
CN201710372392.8 | 2010.12.28 | CN106967139B | A type of erigeron breviscapus ponicidin crystal form and its preparation method |
CN:201910188258:A | 2010.12.28 | CN109700853A | Composition and application thereof to preparation of medicines for preventing and treating epilepsy |
CN:201710372392:A | 2011.09.19 | CN106967139B | Scutellarin crystal form and preparation method thereof |
CN201710157870.3 | 2011.09.19 | CN106955285A | Application of tilifodiolide and its derivatives in preparing drugs for curing or preventing type II diabetes |
CN201710157170.4 | 2011.12.29 | CN107375273A | Application of fibralactone and its derivatives in preparing drugs for curing or preventing type II diabetes |
CN201710066544.1 | 2011.12.29 | CN106883100A | A type of triacontanol crystal form I and its preparation method |
CN201611234568.5 | 2012.04.06 | CN106727451A | Application of COX‑2 and VEGF inhibitors and triacontanol thereof |
CN201611234568.5 | 2012.10.16 | CN106727451B | Application of COX‑2 and VEGF inhibitors and triacontanol thereof |
CN201610899232.4 | 2012.10.16 | CN107759551A | A method to synthesize scutellarin aglycone |
CN201610899252.1 | 2013.08.21 | CN107759646A | A method to synthesize scutellarin |
CN201610897971.X | 2013.08.21 | CN107759472A | A type of scutellarin midbody and its preparation method and application |
CN201310704464.6 | 2013.12.20 | CN103705531A | Application of scutellarin in preventing and controlling peculiar vascular endothelial injury |
CN201310367211.4 | 2016.10.14 | CN103396348A | Rorifone derivatives and their application in preparing anti-cancer drugs |
CN201310367211.4 | 2016.10.14 | CN103396348B | Rorifone derivatives and their application in preparing anti-cancer drugs |
CN:201611234568:A | 2016.10.14 | CN106727451B | COX-2 and VEGF inhibitor and application of triacontanol thereof |
CN201210391600.6 | 2016.12.28 | CN102875620A | New derivatives of myricetin and their application in preparing drugs |
CN201210391600.6 | 2016.12.28 | CN102875620B | New derivatives of myricetin and their application in preparing drugs |
CN201210098223.7 | 2016.12.28 | CN102633762A | Myricetin sulfoacid and salt compounds and their application |
CN201110450545.9 | 2017.02.07 | CN102584917A | A method to prepare high-purity scutellarin raw drug materials |
CN201110450545.9 | 2017.03.16 | CN102584917B | A method to prepare high-purity scutellarin raw drug materials |
CN201110277789.1 | 2017.03.16 | CN102993249A | A method to prepare scutellarin raw drug materials |
CN201110277789.1 | 2017.05.24 | CN102993249B | A method to prepare scutellarin raw drug materials |
CN201010608605.0 | 2017.05.24 | CN102028623A | Continuous production process method for freeze-drying preparations |
CN201010608605.0 | 2017.05.24 | CN102028623B | Continuous production process method for freeze-drying preparations |
CN200910095152.3 | 2017.12.25 | CN101708181A | Scutellarin injection preparation |
CN200910095152.3 | 2018.02.06 | CN101708181B | Scutellarin injection preparation |
CN200810058967.X | 2018.02.06 | CN101683332B | A method to prepare the high-purity scutellarin salt raw drug materials |
CN200710066155.5 | 2018.02.06 | CN101376668B | A method to prepare the high-purity scutellarin salt raw drug materials |
CN200610010923.0 | 2018.07.19 | CN1899296A | Scutellarin injection preparation and its preparation method |
CN200610010923.0 | 2018.08.17 | CN100406021C | Scutellarin injection preparation and its preparation method |
CN200610010907.1 | 2018.08.17 | CN1850097A | Scutellarin injection preparation and its preparation method |
CN200610010907.1 | 2019.03.13 | CN100396289C | Scutellarin injection preparation and its preparation method |
CN95104038.3 | 2019.03.13 | CN1055844C | Scutellarin injection freeze-drying agent preparation process |
